Cancer BiologybioRxivPreprint
SILAC-Based Quantitative Proteomics Identifies Multifactorial Mechanism of Oxaliplatin Resistance in Pancreatic Cancer Cells
Y. E. Kim, E.-K. Kim, M.-J. Song…·D. Kang
This study uses SILAC-based proteomics to identify proteins involved in oxaliplatin resistance in pancreatic cancer cells, finding that MARCKS and WLS contribute to resistance through AKT and β-catenin signaling.
DOI 10.1101/2020.09.04.283150